Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04091178
What this trial is testing

Vitamin D Supplementation to Correct the Vitamin D Deficiency for Breast Cancer

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 57
Early research (Phase 1)UnknownNCT03749850
What this trial is testing

Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer

Who this might be right for
Metastatic Breast CancerBreast CancerBreast Neoplasms+5 more
UMC Utrecht 12
Early research (Phase 1)Study completedNCT02063724
What this trial is testing

HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer

Who this might be right for
Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Testing effectiveness (Phase 2)Study completedNCT00005879
What this trial is testing

LY353381 in Preventing Breast Cancer in Women With Hyperplasia

Who this might be right for
Breast Cancer
University of Kansas Medical Center 199
Not applicableLooking for participantsNCT07532434
What this trial is testing

A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer

Who this might be right for
Ovarian CancerBreast Cancer
Peking University Third Hospital 480
Testing effectiveness (Phase 2)Study completedNCT00392184
What this trial is testing

Partial Breast Irradiation With Multi-Catheter Brachytherapy for pT1-2pN0 Breast Cancer After Breast Conserving Surgery

Who this might be right for
Breast Cancer
University of Erlangen-Nürnberg Medical School 274
Testing effectiveness (Phase 2)Study completedNCT03518606
What this trial is testing

Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumoursBreast CancerHead and Neck Cancer+2 more
UNICANCER 126
Testing effectiveness (Phase 2)Study completedNCT01425476
What this trial is testing

Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors

Who this might be right for
Breast Cancer
Hartford Hospital 45
Testing effectiveness (Phase 2)Study completedNCT03417544
What this trial is testing

Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC

Who this might be right for
HER2-positive Metastatic Breast CancerCentral Nervous System Metastases
Nancy Lin, MD 19
Not applicableStudy completedNCT00849199
What this trial is testing

Cancer Screening and Prevention Program for High Risk Women

Who this might be right for
Ovarian CancerBreast Cancer
NYU Langone Health 1,452
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07109284
What this trial is testing

SKB264 Combined With KL-A167 Neoadjuvant Therapy for Early-stage, High-risk ER+/HER2- Breast Cancer

Who this might be right for
ER+HER2- Breast Cancer
West China Hospital 55
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Testing effectiveness (Phase 2)Study completedNCT00334542
What this trial is testing

Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Large-scale testing (Phase 3)Looking for participantsNCT06952803
What this trial is testing

Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

Who this might be right for
Prostate Cancer
AstraZeneca 700
Not applicableStudy completedNCT02963740
What this trial is testing

Feasibility of High Levels of Energy Expenditure From Physical Activity for Breast Cancer Survivors

Who this might be right for
Breast Cancer Female
University of Kansas Medical Center 11
Not applicableUnknownNCT04265937
What this trial is testing

ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies

Who this might be right for
Breast CancerGenetic Susceptibility
Fudan University 5,000
Not applicableLooking for participantsNCT06994416
What this trial is testing

A Novel Fluorescent Ductal Needle for Localization and Sampling of High-risk Breast Micro Lesions

Who this might be right for
Mammary TumorNipple Discharge
The Fourth Affiliated Hospital of China Medical University 300
Not applicableUnknownNCT05150535
What this trial is testing

One Week Adjuvant Radiotherapy for Breast Cancer

Who this might be right for
Breast Carcinoma
Sohag University 100
Large-scale testing (Phase 3)Study completedNCT00002784
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 344
Not applicableStudy completedNCT00347568
What this trial is testing

BC-DAISY: A Breast Cancer Decision Aid System

Who this might be right for
Breast Cancer
Rhode Island Hospital 195
Next Page